Bethesda, MD, United States of America

Annemarie H Ralston


Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2000-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Annemarie H. Ralston: A Pioneer in Biopharmaceuticals

Introduction

Annemarie H. Ralston is an innovative inventor based in Bethesda, MD, known for her significant contributions to the field of biopharmaceuticals. With a portfolio of four patents, Ralston has excelled in developing methods that enhance the purification and production of critical biological materials.

Latest Patents

One of Ralston's latest patents, titled "Method for the production of pure virally inactivated butyrylcholinesterase," focuses on purifying butyrylcholinesterase from various biological fluids such as blood and plasma. This invention utilizes cationic exchange chromatography and affinity chromatography to achieve purification while ensuring viral inactivation. Additionally, it allows for the resulting product to be stored or lyophilized in a sodium chloride/sodium phosphate solution.

Another notable patent is "Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate." This method involves converting pure prothrombin into thrombin by treating it with sodium citrate without the need for additional coagulation factors. Ralston's technique emphasizes the use of a sodium citrate solution, demonstrating her commitment to enhancing the efficiency of biopharmaceutical processes.

Career Highlights

Annemarie H. Ralston is currently associated with the American National Red Cross, where she leverages her expertise to contribute to the advancement of health-related biotechnologies. Her work is instrumental in ensuring the safety and effectiveness of blood products and other biological materials.

Collaborations

Throughout her career, Ralston has collaborated with esteemed colleagues, including William N. Drohan and Shirley I. Miekka. These partnerships have enabled her to work on innovative solutions that address significant challenges in the field of biopharmaceuticals, making a lasting impact on the industry.

Conclusion

Annemarie H. Ralston's dedication to innovation and her impressive patent portfolio underscore her role as a key figure in the biopharmaceutical sector. Her work not only demonstrates technical excellence but also contributes significantly to advancements in medical science, potentially improving outcomes for patients who rely on these vital therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…